SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-302373
Filing Date
2011-11-08
Accepted
2011-11-08 17:09:02
Documents
10
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d234783d10q.htm 10-Q 669827
2 OFFER LETTER d234783dex101.htm EX-10.1 12545
3 CERTIFICATION OF CEO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) d234783dex311.htm EX-31.1 10075
4 CERTIFICATION OF CFO PURSUANT TO RULES 13A-14(A) AND 15D-14(A) d234783dex312.htm EX-31.2 10111
5 CERTIFICATIONS OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350 d234783dex321.htm EX-32.1 5239
  Complete submission text file 0001193125-11-302373.txt   2415167

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT jazz-20110930.xml EX-101.INS 341105
7 XBRL TAXONOMY EXTENSION SCHEMA jazz-20110930.xsd EX-101.SCH 12962
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE jazz-20110930_cal.xml EX-101.CAL 38906
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE jazz-20110930_lab.xml EX-101.LAB 114193
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE jazz-20110930_pre.xml EX-101.PRE 76521
Mailing Address 3180 PORTER DRIVE PALO ALTO CA 94304
Business Address 3180 PORTER DRIVE PALO ALTO CA 94304 650-496-3777
JAZZ PHARMACEUTICALS INC (Filer) CIK: 0001232524 (see all company filings)

IRS No.: 050563787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33500 | Film No.: 111188637
SIC: 2834 Pharmaceutical Preparations